GCP
TMCI icon

GSA Capital Partners’s Treace Medical Concepts TMCI Stock Holding History

GSA Capital Partners’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$533K Buy
398,007
+50,252
+14% +$100K 0.03% 876
2025
Q4 		$852K Buy
347,755
+236,477
+213% +$1.03M 0.07% 454
2025
Q3 		$747K Buy
111,278
+32,336
+41% +$211K 0.06% 591
2025
Q2 		$464K Buy
78,942
+12,152
+18% +$79.2K 0.03% 970
2025
Q1 		$560K Buy
+66,790
New +$600K 0.05% 721
2024
Q4 		– Sell
-149,129
Closed -$865K – 2031
2024
Q3 		$865K Sell
149,129
-42,298
-22% -$272K 0.07% 565
2024
Q2 		$1.27M Buy
191,427
+122,154
+176% +$987K 0.09% 354
2024
Q1 		$904K Sell
69,273
-9,318
-12% -$124K 0.07% 505
2023
Q4 		$1M Buy
+78,591
New +$794K 0.08% 393

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GSA Capital Partners's TMCI Position: Q1 2026 in Review

GSA Capital Partners increased its Treace Medical Concepts (TMCI) stake by 14% in Q1 2026, buying an estimated $100K and bringing the position to 398,007 shares worth $533K. The position accounts for 0.03% of the portfolio, ranked #876.

GSA Capital Partners first reported a position in TMCI in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.27M in Q2 2024. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • GSA Capital Partners held 398,007 shares of Treace Medical Concepts worth $533K as of Q1 2026.
  • GSA Capital Partners bought 50,252 Treace Medical Concepts shares in Q1 2026, an estimated $100K.
  • Treace Medical Concepts made up 0.03% of GSA Capital Partners's portfolio in Q1 2026, its #876 holding.
  • GSA Capital Partners first reported a position in Treace Medical Concepts in Q4 2023 and has held it in 9 quarters since.
  • GSA Capital Partners's Treace Medical Concepts position peaked at $1.27M in Q2 2024.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.